Search Count: 15
 |
Hepatitis B Virus Core Protein Y132A Mutant In Complex With Thpp Derivatives 48
Organism: Hepatitis b virus adw/991
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-10-25 Classification: VIRAL PROTEIN Ligands: IPA, VX0, GOL |
 |
Hepatitis B Virus Core Protein Y132A Mutant In Complex With Linvencorvir (Rg7907), A Hepatitis B Virus (Hbv) Core Protein Allosteric Modulator (Cpam)
Organism: Hepatitis b virus subtype adyw
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-03-22 Classification: VIRAL PROTEIN Ligands: CL, IPA, GOL, OTI, DMS |
 |
Hepatitis B Virus Core Protein Y132A Mutant In Complex With Sulfamoylbenzamide (Sba_R01)
Organism: Hepatitis b virus
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2017-02-22 Classification: VIRAL PROTEIN Ligands: K89, IPA, DMS, GOL, CL |
 |
Hepatitis B Virus Core Protein Y132A Mutant In Complex With Heteroaryldihydropyrimidine (Hap_R01)
Organism: Hepatitis b virus
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2017-02-22 Classification: VIRAL PROTEIN Ligands: 7TL, IPA, CL, GOL |
 |
Organism: Hepatitis b virus
Method: X-RAY DIFFRACTION Resolution:2.62 Å Release Date: 2017-02-22 Classification: VIRAL PROTEIN Ligands: CL |
 |
Binding Site Elucidation And Structure Guided Design Of Macrocyclic Il-17A Antagonists
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2016-08-31 Classification: IMMUNE SYSTEM/INHIBITOR Ligands: 63O |
 |
Binding Site Elucidation And Structure Guided Design Of Macrocyclic Il-17A Antagonists
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-08-31 Classification: IMMUNE SYSTEM/INHIBITOR Ligands: 63P |
 |
Binding Site Elucidation And Structure Guided Design Of Macrocyclic Il-17A Antagonists
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-08-31 Classification: IMMUNE SYSTEM/INHIBITOR Ligands: 63Q |
 |
Crystal Structure Of Pbp3 In Complex With Compound 14 ((2E)-2-({[(2S)-2-{[(2Z)-2-(2-Amino-1,3-Thiazol-4-Yl)-2-{[(1,5-Dihydroxy-4-Oxo-1,4-Dihydropyridin-2-Yl)Methoxy]Imino}Acetyl]Amino}-3-Oxopropyl]Oxy}Imino)Pentanedioic Acid)
Organism: Pseudomonas aeruginosa pa1r
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2014-05-07 Classification: transferase/transferase inhibitor Ligands: 2U2 |
 |
Crystal Structure Of Pbp3 In Complex With Bal30072 ((2Z)-2-(2-Amino-1,3-Thiazol-4-Yl)-2-{[(1,5-Dihydroxy-4-Oxo-1,4-Dihydropyridin-2-Yl)Methoxy]Imino}-N-{(2S)-1-Hydroxy-3-Methyl-3-[(Sulfooxy)Amino]Butan-2-Yl}Ethanamide)
Organism: Pseudomonas aeruginosa pa1r
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-05-07 Classification: transferase/transferase inhibitor Ligands: 2U3 |
 |
Crystal Structure Of Pbp1A In Complex With Compound 17 ((4Z,8S,11E,14S)-5-(2-Amino-1,3-Thiazol-4-Yl)-14-(5,6-Dihydroxy-1,3-Dioxo-1,3-Dihydro-2H-Isoindol-2-Yl)-8-Formyl-2-Methyl-6-Oxo-3,10-Dioxa-4,7,11-Triazatetradeca-4,11-Diene-2,12,14-Tricarboxylic Acid)
Organism: Pseudomonas aeruginosa pao1
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2014-05-07 Classification: transferase/transferase inhibitor Ligands: 2U4 |
 |
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2013-08-21 Classification: Penicillin Binding Protein/Antibiotic Ligands: PFV |
 |
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2012-10-17 Classification: PENICILLIN-BINDING PROTEIN/ANTIBIOTIC Ligands: 0W0 |
 |
Crystal Structure Of The Von Willebrand Factor A Domain Of Human Capillary Morphogenesis Protein 2: An Anthrax Toxin Receptor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2004-04-13 Classification: MEMBRANE PROTEIN Ligands: ACT, MG |
 |
Crystal Structure Of The Von Willebrand Factor A Domain Of Human Capillary Morphogenesis Protein 2: An Anthrax Toxin Receptor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2004-04-13 Classification: MEMBRANE PROTEIN Ligands: MG |